Search Results 141-150 of 15885 for GLP-1 agonist

  1. Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after ... Current treatment with glucagon-like peptide-1 receptor agonists (GLP-1RA) ...

  2. Empagliflozin (oral route) - Side effects & dosage - Mayo Clinic

    This helps lower the blood sugar level. Empagliflozin does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use ...

  3. Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home - Mayo Clinic

    Subject is using pramlintide (Symlin), SGLT2 inhibitors, GLP agonists, biguanides, DPP-4 inhibitors or sulfonylureas at time of screening. Subject has a ...

  4. Glipizide (oral route) - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. ... You may report side effects to ...

  5. Empagliflozin and linagliptin (oral route) - Side effects & dosage - Mayo Clinic

    This medicine does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use insulin injections. This medicine is ...

  6. Empagliflozin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    It does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use insulin injections. This medicine is available ...

  7. Publications - Emily E. Sharpe, M.D. - Mayo Clinic

    Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. Anesth Analg. 2025 Oct 1 Epub ...

  8. Curriculum - Headache Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    ... GLP-1 agonists) management and determine when to refer for interventional treatment. Research. During your core rotation, you will have time with one to two ...

  9. Publications - Sumera R. Ahmad, M.B.B.S. - Mayo Clinic

    Impact of Glucagon-Like Peptide-1 Receptor Agonist Exposure on Gastrointestinal Outcomes Among ICU Patients: A Multicenter Matched Cohort Study. Crit Care ...

  10. Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes - Mayo Clinic

    Subject has type 1 diabetes for more than one year Study specific inclusion criteria. ... Subject is using pramlintide (Symlin), SGLT2 inhibitors, GLP agonists ...